Kyocera (OTCMKTS:KYOCY) Updates FY 2025 Earnings Guidance

Kyocera (OTCMKTS:KYOCY) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 0.340-0.340 for the period. The company issued revenue guidance of $13.6 billion-$13.6 billion.

Kyocera Stock Performance

KYOCY stock traded down $0.21 during trading on Friday, reaching $9.91. 74,839 shares of the stock were exchanged, compared to its average volume of 125,614. Kyocera has a twelve month low of $9.87 and a twelve month high of $15.63. The company has a market capitalization of $13.96 billion, a P/E ratio of 19.57, a price-to-earnings-growth ratio of 1.74 and a beta of 0.29. The stock has a 50 day simple moving average of $11.66 and a 200-day simple moving average of $11.76. The company has a current ratio of 3.13, a quick ratio of 1.91 and a debt-to-equity ratio of 0.06.

Kyocera (OTCMKTS:KYOCY) last released its earnings results on Thursday, August 1st. The company reported $0.17 earnings per share for the quarter, topping analysts’ consensus estimates of $0.14 by $0.03. The firm had revenue of $3.20 billion for the quarter, compared to analyst estimates of $3.22 billion. As a group, sell-side analysts anticipate that Kyocera will post 0.51 earnings per share for the current year.

About Kyocera

Kyocera Corporation develops, produces, and distributes products based on fine ceramic technologies in Japan, rest of Asia, Europe, the United States, and internationally. It operates through Core Components Business, Electronic Components Business, and Solutions Business segments. The Core Components Business segment offers components, such as fine ceramic components for semiconductor processing equipment, automotive camera modules, and ceramic packages, as well as organic packages and boards to protect electronic components and ICs to industrial machinery, automotive-related, and the information and communication-related markets; optical components, and jewelry and applied ceramic related products; and medical devices comprising prosthetic joints and dental implants.